Regarding CEACAM1 deregulation during tumor progression, CEACAM1 is considered to be downregulated in breast, colon, endometrium, prostate, and hepatocellular carcinomas, suggesting a tumor suppressor role of this molecule, but it is upregulated in gastric carcinoma, squamous cell carcinoma of the lung, or melanoma [27]. The gene discussed is CEACAM1; the disease is gastric carcinoma.